Novel structural features of the human histocompatibility molecules HLA-DQ as revealed by modeling based on the published structure of the related molecule HLA-DR1

Journal of Structural Biology

Volumn 117, Issue 2, 1996, Pages 145-163

  Paliakasis, Kostas ^a   Routsias, John ^b   Petratos, Kyriacos ^a   Ouzounis, Christos ^c   Kokkinidis, Michael ^a   Papadopoulos, George K ^b  

^a Research Center of Crete   (Greece)

^b UNIVERSITY OF IOANNINA   (Greece)

^c EUROPEAN MOLECULAR BIOLOGY LABORATORY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HLA DQ ANTIGEN;

ARTICLE; CHEMICAL STRUCTURE; HUMAN; PRIORITY JOURNAL; ULTRASTRUCTURE;

EID: 0030249410     PISSN: 10478477     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsbi.1996.0079     Document Type: Article

References (89)

1. Adler, M., Lazarus, R. A., Dennis, M. S., and Wagner, G. (1991) Solution structure of kistrin, a potent platelet aggregation inhibitor and GP IIb-IIIa antagonist, Science 253, 445-448.
2. Altman, D. M., Sansom, D., and Marsh, S. G. E. (1991) What is the basis of HLA-DQ associations with autoimmune disease? Immunol. Today 12, 267-270.
3. Andersen, L. C., Beaty, J. S., Nettles, J. W., Seyfried, C. E., Nepom, G. T., and Nepom, B. S. (1991) Allelic polymorphism in transcriptional regulatory regions of HLA-DQB genes, J Exp. Med. 215, 181-192.
4. Baekkeskov, S., Aanstood, H.-J., Christgau, S., Reetz, A., Solimena, M., Cascalho, M., Folli, H., Richter-Olesen, H., and de Camilli, P. (1990) Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase, Nature 345, 151-156.
5. Bairoch, A., and Boeckman, B. (1991) The SWISS-PROT protein sequence data bank, Nucleic Acids Res. 19, 2247-2249.
6. Banner, D. W., D'Arcy, A., Janes, W., Gentz, R., Schoenfelt, H.-J., Broger, C., Loetscher, H., and Lesslauer, W. (1993) Crystal structure of the soluble human 55 kd TNF receptor-human TNFβ complex: implications for TNF receptor activation, Cell 73, 431-145.
7. Bjorkman, P. J., Saper, M. A., Samroui, B., Bennett, W. S., Strominger, J. L., and Wiley, D. C. (1987) Structure of the human class I histocompatibility antigen HLA-A2, Nature 329, 506-512.
8. Bourguet, W., Ruff, M., Chambon, P., Gronemeyer, H., and Moras, D. (1995) Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-α, Nature 375, 377-382.
9. Briata, P., Radka, S. F., and Sartoris, S. (1989) Alternative splicing of HLA-DQ transcripts and secretion of HLA-DQ β chain protein: Allelic polymorphism in splicing and polyadenylation sites, Proc. Natl. Acad. Sci. USA 86, 1003-1007.
10. Brown, J. H., Jardetzky, T., Saper, M. A., Samraoui, B., Bjorkman, P. J., and Wiley, D. C. (1988) A hypothetical model of the foreign antigen binding site of class II histocompatibility molecules, Nature 332, 845-850.
11. Brown, J. H., Jardetzky, T. S., Gorga, J. C., Stern, L. J., Urban, R. G., Strominger, J. L., and Wiley, D. C. (1993) Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1, Nature 364, 33-39.
12. Brugge, J. S. (1994) Protein:protein interactions involved in intracellular signal transduction, Chem. Biol., introductory issue, 15 April, xii-xiii.
13. Cammarota, G., Scheirle, A., Tacaks, B., Doran, D. M., Knorr, R., Bannworth, W, Guardiola, J., and Sinigaglia, F. (1992) Identification of a CD4 binding site on the β2 domain of HLA-DR molecules, Nature 356, 799-801.
14. Campbell, R. D., and Trowsdale, J. (1993) Map of the human MHC, Immunol. Today 14, 349-352.
15. de Vos, A. M., Ultsch, M., and Kossiakof, A. A. (1992) Human growth hormone and extracellular domain of its receptor: crystal structure of the complex, Science 255, 306-312.
16. Eck, M. J., and Sprang, S. R. (1989) The structure of tumor necrosis factor-α at 2.6 Å resolution: implications for receptor binding, J. Biol. Chem. 264, 17595-17605.
17. Emsley, J., White, H. E., O'Hara, B. P., Oliva, G., Srinivasan, N., Tickle, I. J., Blundell, T. L., Pepys, M. B., and Wood, S. P. (1994) Structure of pentameric serum amyloid P component, Nature 367, 338-345.
18. Engelman, D. M., Steitz, T. A., and Goldman, A. (1986). Identifying non-polar transbilayer helices in amino acid sequences of membrane proteins, Annu. Rev. Biophys. Biophys. Chem. 15, 321-353.
19. Falk, K., Rötzschke, O., Stefanovic, S., Jung, G., and Rammensee, H.-G. (1994) Pool sequencing of natural HLA-DR, DQ and DP ligands reveals detailed peptide motifs, constraints of processing and general rules, Immunogenetics 39, 230-242.
20. α, domain of a T cell antigen receptor, Science 270, 1821-1824.
21. Fleury, S., Thibodeau, J., Croteau, G., Labreque, N., Aronson, H.-E., Cantin, C., Long, E. O., and Sêkaly, R.-P. (1995) HLA-DR polymorphism affects the interaction with CD4, J. Exp. Med. 182, 733-741.
22. Fossum, B., Gedde-Dahl III, T., Hansen, T., Eriksen, J. A., Thorsby, E., and Gaudernack, G. (1993) Overlapping epitopes encompassing a point mutation (12Gly → Arg) in p21 ras can be recognised by HLA-DR, -DP, and -DQ restricted T lymphocytes, Eur. J. Immunol. 23, 2687-2691.
23. b, Science 257, 919-927.
24. b-ovalbumin peptide complex reveals the interplay of primary and secondary anchor positions in the major histocompatibility complex binding groove. Proc. Natl. Acad. Sci. USA 92, 2479-2483.
25. Fremont, D. H., Hendrickson, W. A., Marrack, P., and Kappler, J. (1996) Structures of an MHC class II molecule with covalently bound single peptides, Science 272, 1001-1004.
26. Fujisawa, K., Kamikawaji, N., Yasunami, M., Kimura, A., Nishimura, Y., and Sasazuki, T. (1991) High precursor frequency of human T lymphocytes reactive to HLA-DQ molecules expressed on mouse L cells transfectants, Eur. J. Immunol. 21, 2341-2347.
27. Gedde-Dahl III, T., Fossum, B., Eriksen, J. A., Thorsby, E., and Gaudernack, G. (1993) T lymphocyte clones specific for p21 ras-derived peptides: characterization of their fine specificity and HLA restrictions, Eur. J. Immunol. 23, 754-760.
28. Germain, R. N. (1994) MHC-dependent antigen processing and peptide presentation: providing ligands for lymphocyte activation, Cell 76, 287-299.
29. Ghosh, G., Van Duyne, G., Ghosh, S., and Sigler, P. B. (1995a) Structure of NF-κB p50 homodimer bound to a κB site, Nature 373, 303-310.
30. Ghosh, P., Amaya, M., Mellins, E., and Wiley D. C. (1995b) The structure of an intermediate in class II MHC maturation: CLIP bound to HLA-DR3, Nature, 378, 457-462.
31. Goodman, S., Sawada, T., Barbosa, J. A., Cole, B., Pergolizzi, R., Silver, J., Mellins, E., and Chang, M.-der Y (1995) Mutational analysis of two DRα residues involved in dimers of HLA-DR molecules, J. Immunol. 155, 1210-1217.
32. Grimes, J., Basak, A. K., Roy, P., and Stuart, D. (1995) The crystal structure of bluetongue virus VP7, Nature 373, 167-170.
33. Gustafsson, K., LeGuern, C., Hirsch, F., Germana, S., Pratt, K., and Sachs, D. H. (1990) Class II MHC genes of miniature swine IV: Characterization and expression of two allelic class II DQB cDNA clones, J. Immunol. 145, 1946-1951.
34. Haas, T. A., and Plow, E. F. (1994) Integrin-ligand interactions: a year in review. Curr. Opin. Cell Biol. 6, 656-662.
35. Hirayama, K., Matsushita, S., Kikuchi, I., Iuchi, M., Ohta, N., and Sasazuki, T. (1987) HLA-DQ is epistatic to HLA-DR in controlling the immune response to schistosomal antigens in humans, Nature 327, 426-429.
36. Holowachuk, E. W., and Greer, M. K. (1989) Unaltered class II histocompatibility antigens and pathogenesis of IDDM in BB rats, Diabetes 38, 267-271.
37. Huard, B., Prigent, P., Tournier, M., Bruniquel, D., and Triebel, F. (1995) CD4/major histocompatibility complex class II interaction analyzed with CD4-and lymphocyte activation gene-3 (LAG-S)-Ig fusion proteins, Eur. J. Immunol. 25, 2718-2721.
38. Hynes, R. O. (1992) Integrins: Versality, modulation and signaling in cell adhesion, Cell 69, 11-25.
39. Ihle, J. N., Witthuhn, B. A., Quelle, F. W., Yamamoto, K., Thierfelder, W. E., Kreider, B., and Silvennoinen, O. (1994) Signaling by the cytokine receptor superfamily: JAKs and STATs, Trends Bioch. Sci. 19, 222-227.
40. Janeway, C. A., Jr. (1992) The T cell receptor as a multicomponent signalling machine: CD4/CD8 coreceptors and CD45 in T cell activation, Annu. Rev. Immunol. 10, 645-674.
41. Janossy, G., Bofill, M., Poulter, L. W., Rawlings, E., Burford, G., Navarrette, C., Ziegler, A., and Kelemen, E. (1986) Separate ontogeny of two macrophage-like accessory cell populations in the human fetus, J. Immunol. 136, 4354-4361.
42. Jardetzky, T. S., Gorga, J. C., Busch, J., Rothbard, J., Strominger, J. L. and Wiley, D. C. (1990) Peptide binding to DR1: A peptide with most residues substituted to alanine retains binding, EMBO J. 9, 1797-1803.
43. Jardetzky, T. S., Brown, J. H., Gorga, J. C., Stern, L. J., Urban, R. G., Chi, U.-i., Stauffacher, C., Strominger, J. L., and Wiley, D. C. (1994) Three-dimensional structure of a human class II histocompatibility molecule complexed with superantigen. Nature 368, 711-718.
44. Johansen, B. H., Buus, S., Vartal, F., Viken, H., Eriksen, J. A., Thorsby, E., and Sollid, L. M. (1994) Binding peptides to HLA-DQ molecules: peptide binding properties of the disease-associated HLA-DQ (α1*0501, β1*0201) molecule, Int. Immunol. 6, 453-461.
45. Jones, C. M., Lake, R. A., Lamb, J. R., and Faith, A. (1994) Degeneracy of T lymphocyte receptor recognition of an influenza virus hemagglutinin epitope restricted by HLA-DQ and -DR class II molecules, Eur. J. Immunol. 24, 1137-1142.
46. Kabat, E. A., Wu, T. T., Reid-Miller, M., and Gottesman, K. S. (1991) Sequences of Proteins of Immunological Interest, 5th ed., Public Health Service, NIH, Washington, DC.
47. Kim, J., Urban, R. G., Strominger, J. L., and Wiley, D. C. (1994) Toxic shock syndrome toxin-1 complexed with a class II major histocompatibility molecule HLA-DR1, Science 266, 1870-1874.
48. König, R., Huang, Y.-L. and Germain, R. N. (1992) MHC class II interaction with CD4 mediated by a region analogous to the MHC class I binding site for CD8, Nature 356, 796-798.
49. König, R., Shen, X., and Germain, R. N. (1995) Involvement of both major histocompatibility complex class II α and β chains in CD4 function indicates a role for ordered oligomerisation in T lymphocyte activation, J. Exp. Med. 182, 779-787.
50. + T lymphocytes, J. Exp. Med. 173, 759-762.
51. Kwok, W. W., Nepom, G. T., and Raymond, F. C. (1995) HLA-DQ polymosphisms are highly selective for peptide binding interactions, J. Immunol. 155, 2468-2476.
52. Kwok, W. W., Domeier, M. E., Raymond, F. C., Byers, P., and Nepom, G. T. (1996a) Allele-specific motifs characterize HLA-DQ interactions with a diabetes associated peptide derived from glutamic acid decarboxylase, J. Immunol. 156, 2171-2177.
53. Kwok, W. W., Domeier, M. E., Johnson, M. L., and Nepom, G. T. (1996b) HLA-DQB1 codon 57 is critical for peptide binding and recognition, J. Exp. Med. 183, 1253-1258.
54. Lane, P. J. L., McConnell, F. M., Schieven, G. L., Clark, E. A., and Ledbetter, J. A. (1990) The role of class II molecules in human B cell activation: Association with phosphatidyl inositol turnover, protein tyrosine phosphorylation and proliferation, J. Immunol. 144, 3684-3692.
55. Leahey, D. J., Hendrickson, W. A., Aukhil, I., and Erickson, H. P. (1992) Structure of a fibronectin type III domain for tenascin phased by MAD analysis of the selenomethionyl protein, Science 258, 987-991.
56. Lotteau, V., Teyton, R., Burroughs, D., Charron, D. (1987) A novel HLA class II molecule (DRαDQβ) created by mismatched isotype pairing, Nature 329, 339-342.
57. Male, D., Champion, B., Cooke, A., and Owen, M. (1991) Advanced Immunology, 2nd ed., Gower, London.
58. Marsh, S. G. E., and Bodmer, J. G. (1995) HLA class II region nucleotide sequences, 1995, Tissue Antigens 46, 258-280.
59. Marshall, K. W., Liu, A. F., Canales, J., Perahia, B., Jorgensen, B., Gantzos, R., Aguilar, B., Devaux, B., and Rothbard, J. (1994) Role of polymorphic residues in HLA-DR molecules in allele-specific binding of peptide antigens, J. Immunol. 152, 4946-4957.
60. Matsumura, M., Fremont, D. H., Peterson, P. A., Wilson, I. A. (1992) Emerging principles for the recognition of peptide antigens by MHC class I molecules, Science 257, 927-934.
61. Mooney, NB., Grillot-Courvalin, C., Hivroz, C., and Charron, D. (1989) A role for MHC class II antigens in B-cell activation, J. Autoimmun. 2(Suppl.), 215-223.
62. Morzycka-Wroblewska, E., Harwood, J. I., Smith, J. R., and Kagnoff, M. S. (1993) Structure and evolution of the promoter regions of the DQA genes, Immunogenetics 37, 364-372.
63. Muller, C. W., Rey, F. A., Sodeoka, M., Verdine, G. L., and Harrison, S. C. (1995) Structure of the NF-κB p50 homodimer bound to DNA, Nature, 373, 311-317.
64. Noguchi, C. T., and Schechter, E. M. (1985) Sickle cell hemoglobin polymerisation in solution and in cells, Annu. Rev. Biophys. Biophys. Chem. 14, 239-263.
65. Pellegrini, L., Tam, S., and Richmond, T. J. (1995) Structure of serum response factor core bound to DNA, Nature 376, 490-498.
66. Racciopi, L., Ronchese, F., Matis, L. A., and Germain, R. N. (1993). Peptide-major histocompatibility complex class II complexes with mixed agonist/antagonist properties provide evidence for ligand-related differences in T-cell receptor-dependent intracellular signalling, J. Exp. Med. 177, 1047-1060.
67. Ray, F. A., Heinz, F. X., Mandl, C., Kunz, C., and Harrison, S. C. (1995) The envelope glycoprotein from tick-borne encephalitis virus at 2 Å resolution, Nature 375, 291-298.
68. Routsias, J., and Papadopoulos, G. K. (1995) Polymorphic structural features of modelled HLA-DQ molecules segregate according to susceptibility or resistance to IDDM, Diabetologia 38, 1251-1261.
69. Sakihama, T., Smolyar, A., and Reinherz, E. L. (1995) Oligomerisation of CD4 is required for stable binding to class II major histocompatibility complex proteins but not for interaction with human immunodeficiency virus gp120, Proc. Natl. Acad. Sci. USA 92, 6444-6448.
70. + T lymphocytes is receptor dependent and HLA-DQ restricted, Proc. Natl. Acad. Sci. USA 88, 2598-2602.
71. Sanjeevi, C. B., Lybrand, T. P., DeWeese, C., Landin-Olsson, M., Kockum, I., Dahlquist, G., Sundqvist, G., Stenger, D., Lernmark, Å., and the members of the Swedish Childhood Diabetes Study (1995) Polymorphic amino acid variations in HLA-DQ are associated with systemic physical property changes and occurrence of IDDM, Diabetes 44, 125-131.
72. Saudek, V., Atkinson, R. A. and Pelton, J. T. (1991) Three-dimensional structure of echistatin, the smallest active RGD protein, Biochemistry 30, 7369-7372.
73. d molecules, J. Immunol. 143, 3289-3294.
74. Sidney, J., Oseroff, C., del Guercio, M.-F., Southwood, S., Kroeger, J. I., Ishioka, G. Y., Sagaguchi, K., Appella, E., and Sette, A. (1994) Definition of a DQ3.1-specific binding motif, J. Immunol. 152, 4516-1525.
75. Samanen, J., Ali, F., Romoff, T., Calvo, R., Sorenson, E., Vasko, J., Storer, B., Berry, D., Bennet, D., Strohsacker, M., Powers, D., Stadel, J., and Nicholls, A. (1991) Development of a small RGD peptide fibrinogen receptor antagonist with potent antiaggregatory activity in vitro, J. Med. Chem. 35, 3114-3125.
76. Sinigaglia, F. (1995) Peptide binding by disease-associated MHC-class II molecules, Symposium (S6) lecture, 9th International Congress of Immunology, 23-29 July, San Francisco, CA.
77. Srinivasan, N., and Blundell, T. L. (1993) An evaluation of the performance of an automated procedure for comparative modelling of protein tertiary structure, Protein Eng. 6, 501-510.
78. St. Charles, R., Harrison, R. W., Bell, G. I., Pilkis, S. J., and Weber, I. (1994) Molecular model of human β-cell glucokinase built by analogy to the crystal structure of yeast hexokinase B, Diabetes, 43, 784-791.
79. Stern, L. J., Brown, J. H., Jardetzky, T. S., Gorga, J. C., Urban, R. G., Strominger, J. L., and Wiley, D. C. (1994) Crystal structure of a human class II MHC protein HLA-DR1 complexed with an influenza virus peptide, Nature 368, 215-221.
80. Stern, L. J. (1995) A complex of HLA-DR1 with a peptide from HLA-A8, Symposium (S6) lecture, 9th International Congress of Immunology, 23-29 July, San Francisco, CA, USA, 23-29 July.
81. Stryer, L. (1995) Biochemistry, 4th ed., p. 284, Freeman, New York.
82. Trowsdale, J., and Campbell, R. D. (1992) Complexity in the major histocompatibility complex, Eur. J. Immunogenet. 19, 43-55.
83. van de Wal, Y., Kooy, Y. M. C., Drijfhout, J. W., Amons, R., and Koning, F. (1996) Peptide-binding characteristics of the coeliac disease-associated DQ(α1*0501, β1*0201) molecule. Immunogenetics, in press.
84. Verreck, F. A. W., Termijtelen, A., and Koning, F. (1993) HLA-DRβ chain residue 86 controls DRαβ dimer stability, Eur. J. Immunol. 23, 1346-1350.
85. Weber, I., Miller, M., Jaskolski, M., Leis, J., Skalka, A. M., and Wlodawer, A. (1989) Molecular modeling of HIV-1 protease and its substrate binding site, Science 243, 928-931.
86. Wlodawer, A., Miller, M., Jaskolski, M., Sathyanarayana, B. K., Baldwin, E., Weber, I. T., Selk, L. M., Clawson, L., Schneider, J., and Kent, S. B. H. (1989) Conserved folding in retrovial proteases: Crystal structure of a synthetic HIV-1 protease, Science 245, 616-621.
87. Woolfrey, A. E., and Nepom, G. T. (1995) Differential transcriptional elements direct expression of HLA-DQ genes, Clin. Immunol. Immunopathol. 74, 119-126.
88. Wucherpfennig, K. W., Yu, B., Bhol, K., Monos, D. S., Argyris, E., Karr, R. W., Ahmed, A. R., and Strominger, J. L. (1995) Structural basis for major-histocompatibility complex (MHC)-linked suscpetibility to autoimmunity: Charged residues of a single MHC binding pocket confer selective presentation of self peptides in pemphigus vulgaris, Proc. Natl. Acad. Sci. USA 92, 11935-11939.
89. Yamada, T., Uyeda, A., Kidera, A., and Kikuchi, M. (1994) Functional analysis and modeling of a conformationally constrained Arg-Gly-Asp sequence inserted into human lysozyme, Biochemistry 33, 11678-11683.